Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

FRA/ZEG stock hub

FRA/ZEG has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/ZEGis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

239.6B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/ZEG

In the news

Latest news · FRA/ZEG

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E17.1

P25 n/aP50 n/aP75 n/a

Trailing P/E26.6

P25 n/aP50 n/aP75 n/a

ROE23.5

P25 n/aP50 n/aP75 n/a

ROIC16.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/ZEG market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	DE
Employees	96,100
Employees Change	4,400%
Employees Change Percent	4.89
Enterprise value	EUR 262.7B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	EUR 239.6B
Price	EUR 154
Price currency	EUR
Rev Per Employee	545,460.4x
Sic	2834
Symbol	fra/ZEG
Website	https://www.astrazeneca.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.76%
EV Earnings	29.16x
EV/EBIT	20.1x
EV/EBITDA	14.7x
EV/FCF	26.83x
EV/Sales	4.96x
FCF yield	4.09%
Forward P/E	17.11x
P/B ratio	5.83x
P/E ratio	26.59x
P/S ratio	4.57x
PE Ratio10 Y	84.81x
PE Ratio3 Y	31.68x
PE Ratio5 Y	131.57x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	24.69%
EBITDA Margin	33.08%
FCF margin	18.68%
Gross margin	81.51%
Gross Profit	EUR 42.7B
Gross Profit Growth	8.69%
Gross Profit Growth Q	11.17%
Gross Profit Growth3 Y	10.18%
Gross Profit Growth5 Y	17.61%
Net Income	EUR 9B
Net Income Growth	33.67%
Net Income Growth Q	5.62%
Net Income Growth3 Y	30.22%
Net Income Growth5 Y	21.17%
Pretax Margin	21.37%
Profit Margin	17.19%
Profit Per Employee	EUR 93,760
ROA	8.47
Roa5y	5.95
ROCE	18.32
ROE	23.48
Roe5y	13.03
ROIC	16.4
Roic5y	13.29

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	16%
Cagr15y	13.88%
Cagr1y	32.25%
Cagr3y	7.71%
Cagr5y	15%
Div CAGR10	0.85%
Div CAGR3	-0.54%
Div CAGR5	2.74%
EPS Growth	33.61
EPS Growth Q	5.35
EPS Growth3 Y	30.03
EPS Growth5 Y	16.98
FCF Growth	1.26%
FCF Growth Q	-14.37%
FCF Growth3 Y	9.55%
FCF Growth5 Y	15.06%
OCF Growth	8.66%
OCF Growth Q	-9.53%
OCF Growth10 Y	11.98%
OCF Growth3 Y	13.57%
OCF Growth5 Y	16.62%
Revenue Growth	9.93x
Revenue Growth Q	12.51x
Revenue Growth3 Y	11.3x
Revenue Growth5 Y	16.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.55
Assets	EUR 98.9B
Cash	EUR 6.7B
Current Assets	EUR 25.1B
Current Liabilities	EUR 27.6B
Debt	EUR 29.5B
Debt EBITDA	EUR 1.67
Debt Equity	EUR 0.72
Debt FCF	EUR 3.01
Equity	EUR 41.1B
Interest Coverage	10.59
Liabilities	EUR 57.8B
Long Term Assets	EUR 73.8B
Long Term Liabilities	EUR 30.2B
Net Cash	EUR -22.9B
Net Cash By Market Cap	EUR -9.54
Net Debt EBITDA	EUR 1.32
Net Debt Equity	EUR 0.56
Net Debt FCF	EUR 2.33
Tangible Book Value	EUR -9.3B
Tangible Book Value Per Share	EUR -6.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.91
Inventory Turnover	1.8
Net Working Capital	EUR -2.2B
Quick ratio	0.7
Working Capital	EUR -2.6B
Working Capital Turnover	EUR -17.63

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.08%
Dividend Growth	-7.66%
Dividend Growth Years	4%
Dividend per share	EUR 2.71
Dividend Years	30
Dividend Yield	1.69%
Ex Div Date	2026-02-19
Last Dividend	EUR 1.83
Payout Frequency	Semi-Annual
Payout Ratio	46.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	340.86%
1Y total return	32.22%
200-day SMA	152.7
3Y total return	24.96%
50-day SMA	167.1
50-day SMA vs 200-day SMA	50over200
5Y total return	101.15%
All Time High	180.5
All Time High Change	-10.94%
All Time High Date	2026-02-18
All Time Low	23.97
All Time Low Change	570.42%
All Time Low Date	2009-03-27
ATR	3.97
Ch YTD	1.52
High	154.2
High52	180.5
High52 Date	2026-02-18
High52ch	-14.55%
Low	153
Low52	115.4
Low52 Date	2025-05-12
Low52ch	33.62%
Ma50ch	-3.82%
Price vs 200-day SMA	5.24%
RSI	34.04
RSI Monthly	55.39
RSI Weekly	46.65
Sharpe ratio	0.93x
Sortino ratio	1.76
Total Return	1.77%
Tr YTD	2.56
Tr15y	602.5%
Tr1m	-5.55%
Tr1w	1.58%
Tr3m	0.53%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 12.9B
Operating Income Growth	10.65
Operating Income Growth Q	17.2
Operating Income Growth3 Y	14.17
Operating Income Growth5 Y	29.99
Operating margin	24.69

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,543,451,508%
Net Borrowing	1,010,770,704
Shares Insiders	0.04%
Shares Institutions	68.53%
Shares Qo Q	-0.13%
Shares Yo Y	-0.08%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 9.5B
Average Volume	615.9x
Bv Per Share	26.5
CAPEX	EUR -2.5B
Ch10y	231.3
Ch15y	356.9
Ch1m	-5.55
Ch1w	1.58
Ch1y	29.96
Ch3m	-0.5
Ch3y	17.73
Ch5y	81.07
Ch6m	10.11
Change	-0.52%
Change From Open	0.26
Close	155
Days Gap	-0.77
Depreciation Amortization	4,299,167,340
Dollar Volume	20,508.6
Earnings Date	2026-04-29
EBIT	EUR 12.9B
EBITDA	EUR 17.3B
EPS	EUR 5.76
F Score	7
FCF	EUR 9.8B
FCF EV Yield	3.73x
Financing CF	-3,963,561,000
Fiscal Year End	December
Founded	1,992
Goodwill	17,971,706,628
Graham Number	61.22025
Graham Upside	-61.9
Income Tax	EUR 2.2B
Investing CF	-6,372,053,100
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	EUR 128
Lynch Upside	-20.38
Ma150	159.4
Ma150ch	0.81%
Ma20	164.9
Ma20ch	-2.55%
Net CF	2,000,861,100
Next Earnings Date	2026-07-27
Open	153.8
P FCF Ratio	24.46
P OCF Ratio	19.43
Payment Date	2026-03-23
Position In Range	100
Ppne	12,669,400,242
Price Date	2026-05-08
Price EBITDA	EUR 13.82
Relative Volume	0.22x
Revenue	52,418,744,700x
SBC By Revenue	0.61x
Share Based Comp	317,431,800
Tax By Revenue	4.17x
Tax Rate	19.52%
Tr6m	11.24%
Volume	133
Z Score	3.35

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

FRA/ZEG dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.7%

$2.71 annual per share

Payout ratio

+46.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+2.7%

4 consecutive years of growth

Total shareholder yield

+1.8%

Next ex-dividend date: 2026-02-19

Performance

FRA/ZEG stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/ZEG?

Insider, institutional, and short-interest positioning.

Institutional ownership

+68.5%

Share of float held by funds and institutions

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.1%

Negative means the company is buying back shares.

Technical

FRA/ZEG momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.0

Neutral momentum band

Price vs 200-day MA

+5.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.93

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/ZEG

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/ZEG stock rating?

fra/ZEG is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/ZEG analysis?

The full report lives at /stocks/fra/ZEG/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/ZEG?

The latest report frames fra/ZEG around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/ZEG page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.